lansoprazole has been researched along with Middle Ear Effusion in 4 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gastroesophageal reflux (GER) is considered a cause of otitis media with effusion (OME)." | 2.87 | A Clinical Trial of Proton Pump Inhibitors to Treat Children with Chronic Otitis Media with Effusion. ( Dewan, K; Lieu, J, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dewan, K | 1 |
| Lieu, J | 1 |
| Mel-Hennawi, D | 1 |
| Ahmed, MR | 2 |
| Bakshi, SS | 1 |
2 trials available for lansoprazole and Middle Ear Effusion
| Article | Year |
|---|---|
A Clinical Trial of Proton Pump Inhibitors to Treat Children with Chronic Otitis Media with Effusion.
Topics: Acoustic Impedance Tests; Administration, Oral; Audiometry; Audiometry, Pure-Tone; Child; Child, Pre | 2018 |
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Case-Control Studies; Child; Child, Prescho | 2015 |
2 other studies available for lansoprazole and Middle Ear Effusion
| Article | Year |
|---|---|
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; | 2016 |
Authors' reply.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; | 2016 |